共 23 条
[1]
The Relative Bioavailability and Effects of Food and Acid-Reducing Agents on Filgotinib Tablets in Healthy Subjects
[J].
Anderson, Kacey
;
Zheng, Hao
;
Kotecha, Mona
;
Cuvin, Jennifer
;
Scott, Bob
;
Sharma, Shringi
;
Qin, Ann Ran-Ran
;
Namour, Florence
;
Xin, Yan
.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT,
2019, 8 (05)
:585-594

Anderson, Kacey
论文数: 0 引用数: 0
h-index: 0
机构:
Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

Zheng, Hao
论文数: 0 引用数: 0
h-index: 0
机构:
Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

Kotecha, Mona
论文数: 0 引用数: 0
h-index: 0
机构:
Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

Cuvin, Jennifer
论文数: 0 引用数: 0
h-index: 0
机构:
Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

Scott, Bob
论文数: 0 引用数: 0
h-index: 0
机构:
Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

Sharma, Shringi
论文数: 0 引用数: 0
h-index: 0
机构:
Acerta Pharma, San Francisco, CA USA Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

Qin, Ann Ran-Ran
论文数: 0 引用数: 0
h-index: 0
机构:
Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

Namour, Florence
论文数: 0 引用数: 0
h-index: 0
机构:
Galapagos SASU, Romainville, France Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

Xin, Yan
论文数: 0 引用数: 0
h-index: 0
机构:
Horizon Pharma, Brisbane, CA USA Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[2]
[Anonymous], 2012, Ema, DOI DOI 10.1093/DEAFED/ENS058
[3]
Clinical significance of Janus Kinase inhibitor selectivity
[J].
Choy, Ernest H.
.
RHEUMATOLOGY,
2019, 58 (06)
:953-962

Choy, Ernest H.
论文数: 0 引用数: 0
h-index: 0
机构:
Cardiff Univ, Sch Med, Div Infect & Immun, CREATE Ctr,Sect Rheumatol, Tenovus Bldg,Heath Pk, Cardiff CF14 4XN, S Glam, Wales Cardiff Univ, Sch Med, Div Infect & Immun, CREATE Ctr,Sect Rheumatol, Tenovus Bldg,Heath Pk, Cardiff CF14 4XN, S Glam, Wales
[4]
Crispino N, 2021, CLIN EXP RHEUMATOL, V39, P668, DOI 10.55563/clinexprheumatol/e7ayu8
[5]
JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
[J].
Fragoulis, George E.
;
McInnes, Iain B.
;
Siebert, Stefan
.
RHEUMATOLOGY,
2019, 58
:43-54

Fragoulis, George E.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland

McInnes, Iain B.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland

Siebert, Stefan
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland
[6]
Tofacitinib inhibits granulocyte-macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils
[J].
Furuya, Makiko Yashiro
;
Asano, Tomoyuki
;
Sumichika, Yuya
;
Sato, Shuzo
;
Kobayashi, Hiroko
;
Watanabe, Hiroshi
;
Suzuki, Eiji
;
Kozuru, Hideko
;
Yatsuhashi, Hiroshi
;
Koga, Tomohiro
;
Ohira, Hiromasa
;
Sekine, Hideharu
;
Kawakami, Atsushi
;
Migita, Kiyoshi
.
ARTHRITIS RESEARCH & THERAPY,
2018, 20

Furuya, Makiko Yashiro
论文数: 0 引用数: 0
h-index: 0
机构:
Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan

Asano, Tomoyuki
论文数: 0 引用数: 0
h-index: 0
机构:
Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan

Sumichika, Yuya
论文数: 0 引用数: 0
h-index: 0
机构:
Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan

Sato, Shuzo
论文数: 0 引用数: 0
h-index: 0
机构:
Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan

Kobayashi, Hiroko
论文数: 0 引用数: 0
h-index: 0
机构:
Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan

Watanabe, Hiroshi
论文数: 0 引用数: 0
h-index: 0
机构:
Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan

Suzuki, Eiji
论文数: 0 引用数: 0
h-index: 0
机构:
Ohta Nishinouchi Gen Hosp Fdn, Dept Rheumatol, 2-5-20 Nishinouchi, Koriyama, Fukushima 9638558, Japan Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan

Kozuru, Hideko
论文数: 0 引用数: 0
h-index: 0
机构:
NHO Nagasaki Med Ctr, Clin Res Ctr, Kubara 2-1001-1, Omura, Nagasaki 8568562, Japan Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan

Yatsuhashi, Hiroshi
论文数: 0 引用数: 0
h-index: 0
机构:
NHO Nagasaki Med Ctr, Clin Res Ctr, Kubara 2-1001-1, Omura, Nagasaki 8568562, Japan Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan

Koga, Tomohiro
论文数: 0 引用数: 0
h-index: 0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Unit Translat Med, Dept Immunol & Rheumatol, Sakamoto 1-7-1, Nagasaki 8528501, Japan Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan

Ohira, Hiromasa
论文数: 0 引用数: 0
h-index: 0
机构:
Fukushima Med Univ, Sch Med, Dept Gastroenterol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan

Sekine, Hideharu
论文数: 0 引用数: 0
h-index: 0
机构:
Fukushima Med Univ, Sch Med, Dept Immunol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan

Kawakami, Atsushi
论文数: 0 引用数: 0
h-index: 0
机构:
Nagasaki Univ, Grad Sch Biomed Sci, Unit Translat Med, Dept Immunol & Rheumatol, Sakamoto 1-7-1, Nagasaki 8528501, Japan Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan

Migita, Kiyoshi
论文数: 0 引用数: 0
h-index: 0
机构:
Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan Fukushima Med Univ, Sch Med, Dept Rheumatol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan
[7]
Safety, tolerability and pharmacokinetics of WXFL10203614 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase I study
[J].
Huang, Kai
;
Ding, Ying
;
Que, Linling
;
Chu, Nannan
;
Shi, Yunfei
;
Qian, Zhenzhong
;
Qin, Wei
;
Chen, Yuanxin
;
Gu, Xianghong
;
Wang, Jiakun
;
Zhang, Zhiwei
;
Xu, Jianguo
;
He, Qing
.
FRONTIERS IN PHARMACOLOGY,
2022, 13

Huang, Kai
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China

Ding, Ying
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China

Que, Linling
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China

Chu, Nannan
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China

Shi, Yunfei
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China

Qian, Zhenzhong
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China

Qin, Wei
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China

Chen, Yuanxin
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China

Gu, Xianghong
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China

Wang, Jiakun
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China

Zhang, Zhiwei
论文数: 0 引用数: 0
h-index: 0
机构:
Wuxi Fuxin Pharmaceut Res & Dev Co Ltd, Wuxi, Peoples R China Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China

Xu, Jianguo
论文数: 0 引用数: 0
h-index: 0
机构:
Wuxi Fuxin Pharmaceut Res & Dev Co Ltd, Wuxi, Peoples R China Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China

He, Qing
论文数: 0 引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi, Peoples R China
[8]
Extended-Release Once-Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate-Release Tofacitinib and Impact of Food
[J].
Lamba, Manisha
;
Wang, Rong
;
Fletcher, Tracey
;
Alvey, Christine
;
Kushner, Joseph
;
Stock, Thomas C.
.
JOURNAL OF CLINICAL PHARMACOLOGY,
2016, 56 (11)
:1362-1371

Lamba, Manisha
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, Groton, CT 06340 USA Pfizer Inc, Groton, CT 06340 USA

Wang, Rong
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, Groton, CT 06340 USA Pfizer Inc, Groton, CT 06340 USA

Fletcher, Tracey
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, Collegeville, PA USA Pfizer Inc, Groton, CT 06340 USA

Alvey, Christine
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, Groton, CT 06340 USA Pfizer Inc, Groton, CT 06340 USA

Kushner, Joseph
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, Groton, CT 06340 USA Pfizer Inc, Groton, CT 06340 USA

Stock, Thomas C.
论文数: 0 引用数: 0
h-index: 0
机构:
Pfizer Inc, Collegeville, PA USA Pfizer Inc, Groton, CT 06340 USA
[9]
Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors - Similarities and differences
[J].
Lennernas, H
;
Fager, G
.
CLINICAL PHARMACOKINETICS,
1997, 32 (05)
:403-425

Lennernas, H
论文数: 0 引用数: 0
h-index: 0
机构: ASTRA HASSLE AB, MOLNDAL, SWEDEN

Fager, G
论文数: 0 引用数: 0
h-index: 0
机构: ASTRA HASSLE AB, MOLNDAL, SWEDEN
[10]
Randomized, double-blinded, placebo-controlled phase I study of the pharmacokinetics, pharmacodynamics, and safety of KL130008, a novel oral JAK inhibitor, in healthy subjects
[J].
Li, Na
;
Du, Shuangqing
;
Wang, Ying
;
Zhu, Xiaohong
;
Shu, Shiqing
;
Men, Yuchun
;
He, Miao
;
Fang, Fang
;
Wang, Yongsheng
;
Gong, Yimou
;
Chen, Jing
;
Gu, Liling
;
Cheng, Yezhe
;
He, Qiang
;
Lu, Huifang
;
Niu, Yuanyuan
;
Xu, Ying
;
Feng, Ping
.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES,
2022, 176

Li, Na
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China

Du, Shuangqing
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China

Wang, Ying
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China

Zhu, Xiaohong
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China

Shu, Shiqing
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China

Men, Yuchun
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China

He, Miao
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China

Fang, Fang
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China

Wang, Yongsheng
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China

Gong, Yimou
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Kelun Biotech Biopharmaceut Co Ltd, Clin Res Ctr, 666 Xinhua Ave,Chengdu Cross Strait Sci & Technol, Chengdu 611100, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China

Chen, Jing
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Kelun Biotech Biopharmaceut Co Ltd, Clin Res Ctr, 666 Xinhua Ave,Chengdu Cross Strait Sci & Technol, Chengdu 611100, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China

Gu, Liling
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Kelun Biotech Biopharmaceut Co Ltd, Clin Res Ctr, 666 Xinhua Ave,Chengdu Cross Strait Sci & Technol, Chengdu 611100, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China

Cheng, Yezhe
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Kelun Biotech Biopharmaceut Co Ltd, Clin Res Ctr, 666 Xinhua Ave,Chengdu Cross Strait Sci & Technol, Chengdu 611100, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China

He, Qiang
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Kelun Biotech Biopharmaceut Co Ltd, Clin Res Ctr, 666 Xinhua Ave,Chengdu Cross Strait Sci & Technol, Chengdu 611100, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China

Lu, Huifang
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Kelun Biotech Biopharmaceut Co Ltd, Clin Res Ctr, 666 Xinhua Ave,Chengdu Cross Strait Sci & Technol, Chengdu 611100, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China

Niu, Yuanyuan
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Kelun Biotech Biopharmaceut Co Ltd, Clin Res Ctr, 666 Xinhua Ave,Chengdu Cross Strait Sci & Technol, Chengdu 611100, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China

Xu, Ying
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Kelun Biotech Biopharmaceut Co Ltd, Clin Res Ctr, 666 Xinhua Ave,Chengdu Cross Strait Sci & Technol, Chengdu 611100, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China

Feng, Ping
论文数: 0 引用数: 0
h-index: 0
机构:
Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China Sichuan Univ, West China Hosp, Clin Trial Ctr, Natl Med Prod Adm,Key Lab Clin Res & Evaluat Innov, Chengdu 610041, Sichuan, Peoples R China